Release Date: 30/04/21 09:31 Summary: Quarterly Activities Report and Appendix 5B Price Sensitive: Yes Download Document 2.27MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%